Articles, Whitepapers, Videos, Publications.


Please feel free to browse a our library of resources regarding innovations in Patient Adherence.


What mHealth Professionals Keep Asking: Don’t Patients Want to Get Better?

December 20, 2012

Amos Amos Adler, M.Sc. is the Founder & President of MEMOTEXT

Combating the barriers to patient adherence requires a disciplined, and focused and cost-effective approach. This approach must encompass all the stakeholders in the healthcare equation including payors, pharmas and providers. By looking at patient behaviors, motivations and understanding, we can effect change at the patient level. On a systemic level; Payors can save on critical care costs, pharmaceutical manufacturers can stabilize revenue and the system can benefit from less drain on the economy and overall costs. Everyone stands to benefit from increased compliance, most of all…the patient.


Evidence-based mHealth Adherence-related Interventions

Miki Peer Medical Science Liaison, MEMOTEXT                           Journal for Patient Compliance,       Volume 3 Issue 1 2013

Adherence is Transdisciplinary, Perhaps Even its Own ‘Discipline’

The issue of patient adherence is complex and involves interacting dimensions of patient-related factors, social/economic factors, condition-related factors, therapy related factors, and health system/healthcare team factors1. In other words, the nature of the adherence beast is multi-faceted and inherently interdisciplinary. Expert advice informing best practices to improve
patient adherence is needed from healthcare-related clinicians (doctors, nurses, pharmacists), mental health experts (psychologists, psychiatrists), sociologists, social workers, epidemiologists, health-related researchers, and policy-makers (among others). A more appropriate term for how adherence should be properly viewed then may be transdiciplinary. That is, adherence requires a holistic approach, one that seeks to integrate knowledge from all related disciplines into a coherent whole.


Click Bait for Your Health: How a Toronto Startup Uses Digital Engagement to Increase Medication Adherence

Amos Adler Founder and President, MEMOTEXT                                                                                Date Published November 17, 2015

The MaRS Centre for Impact Investing and the Royal Bank of Canada (RBC) are proud to announce the 2015 RBC Impact Entrepreneurs. The Entrepreneurs were showcased at the 8th annual Social Finance Forum.

Using digital engagement to increase medication adherence is our novel solution to a complex problem. With non-adherence caused by multiple factors unique to each individual patient, a-one-size-fits-all-solution can’t work and won’t work. Instead, at MEMOTEXT we personalize each patient’s support program. By encouraging patient input adapting to the changes in their mood and lifestyle we can develop an adherence and support program that works best for them!


Impact Investing Moves from the Margins to the Mainstream

Muska Ulhaq Program Coordinator, MaRS Centre for Impact Investing and Interim- Managing Editor of SocialFinance.ca

Date Published October 26, 2015

Today, we know that the scale of our global problems far exceed the resources currently allocated to solve them. A new breed of investor is now emerging—one that is not only interested in financial returns but also in generating social and environmental value. By mobilizing private capital, impact investing promises to unlock new capital sources to do good.


8 social impact startups you need to know
How cute cat photos may change the way you take care of your health

By    Oct 6, 2015

We’ve all had that “Oops!” moment when we realize we missed a dose of medication. Forgetting to take a birth control pill can be a minor nuisance (albeit one that occasionally results in a baby.) For more serious illnesses, though, forgetting meds can cause serious health complications.

One Canadian company thinks they have a solution: cute cat photos.


Can cute cat texts motivate patients to take their medication?

on October 6th, 2015

The right kind of motivation is key when you have a difficult or mundane task at hand. For example, when I wanted to learn Spanish, I tried several top-rated, online language tools to no avail because they felt like work to me. Then, half as a joke, my boyfriend suggested an app that associates Spanish phrases with images of cats acting out the meaning of the words. The app was so silly I used it often, and — to our amazement — it actually worked.



One company hopes cute cat pictures will convince you to take your medicine

By STEPHANIE BAUM Oct 5, 2015 at 7:56 AM

black cat meme 2

Memotext is trying a different approach as part of its push to trigger a conversation to get patients to change behavior: cute cat images. It is part of a mobile chat bot to automate conversations to improve adherence and fits into a broader program

“We’re not only asking whether you did something, but why did you do it,” Memotext Founder and President Amos Adler said in an interview. “It is mostly about figuring out how to send content to people in the context of their health.”


Announcing Impact8’s 4th Cohort

Kevin Taylor  Senior Associate, MaRS Centre for Impact Investing                                                 Date Published September 22, 2015


Initially launched in 2013, Impact8 helps to close the gap between growth-stage impact based ventures and investors interested in opportunities to fund business with a social benefit. By providing mentorship and targeted workshops, Impact8 increases the pipeline of fundable business, introduces impact start-ups to the fundraising process, and connects social entrepreneurs to investors, partners and experts in the field of social innovation.


PerformRx and MEMOTEXT at BIO2015

Philadelphia, June 15, 2015


MEMOTEXT’s Founder and President Amos Adler and PerformRx’s Director of Drug Therapy Management Programs & Outcomes Lauren C. Megargell, jointly present the results of our HealthNHandSM asthma adherence program to the The Digital Transformation of Patient Care: New Avenues for Pharma Growth Seminar. The seminar was organized by the Consulate General of Canada in New York’s Canadian Technology Accelerator (CTA) Health IT Philadelphia as part of BIO2015.

Will Arizona’s Medicaid beneficiaries use smartphone apps?

By Jonah Comstock | Aug 5, 2015

Arizona Governor Doug Ducey carved out a place for mobile health in his plan for the state’s new Medicaid plan this week, but some critics think the initiative could miss the mark for a low-income population less likely to have smartphones.

Arizona’s Medicaid system, the Arizona Healthcare Cost Containment System (AHCCCS), is a managed care system that operates on a special waiver from the federal government. That waiver is set to expire next September, and Ducey is using that expiration as an opportunity to make changes to the system that he hopes will cut costs by empowering Medicaid users and helping them get back to work. The changes, a plan called “Choice, Accountability, Responsibility and Engagement” (CARE), include health savings accounts, strategic co-pays, and wellness incentives for Medicaid enrollees.


20 Promising Canadian Digital Health Companies to Watch


“A company’s odds of success are better the closer they can get to their market,” argues Stephen Hurwitz, a thought leader in the Canadian venture capital industry, recognizing that the proximity to a VC-tech hub can help the success rate of Canadian startups.

A socialized healthcare system, Canada’s market is fragmented by province and type of care – most primary and emergency care is free for residents whereas specialty care, prescription drugs, long-term and in-home care amongst others, are not covered by the Canada Health Act. This system, while making healthcare much more accessible and affordable for citizens, leaves large gaps in coverage and therefore plenty of niches for companies to address current deficiencies with new products and technologies.


MEMOTEXT Corporation et STI Technologies forment une alliance stratégique pour dynamiser l’observance thérapeutique au Canada

Les deux entreprises associeront les communications numériques et des solutions validées axées sur des programmes de cartes dans l’objectif d’offrir une approche intégrée visant l’amélioration de l’observance des patients envers leurs traitements médicamenteux

TORONTO, le 28 avril 2015 /CNW/ – MEMOTEXT Corporation a annoncé aujourd’hui la formation d’une alliance stratégique avec STI Technologies Limited dans le but d’offrir une plateforme de communication numérique de pointe associée à la technologie des cartes intelligentes afin d’améliorer l’observance thérapeutique.

Les deux entreprises canadiennes collaborent pour associer leurs technologies respectives afin de résoudre un problème très coûteux dans le domaine des soins de santé. Bien que leurs opérations se situent dans des sphères différentes de l’industrie des soins de santé, STI et MEMOTEXT utilisent des méthodologies appuyées par des données probantes et possèdent des solutions validées qui se complètent. Selon un article publié dans JAMA, il a été démontré que les solutions numériques d’observance validées en clinique de MEMOTEXT augmentent l’observance thérapeutique des patients de 31,4 %.


MEMOTEXT Corp. and STI Technologies form Strategic Alliance to Supercharge Patient Adherence in Canada

Companies will combine digital communications and card based validated solutions, to provide integrated approach to increasing patient medication adherence

TORONTO, April 28, 2015 /CNW/ – MEMOTEXT Corp. announces today the formation of a strategic alliance with STI Technologies Limited to provide state-of-the art digital communications platform and smart-card technology, to improve patient compliance with medications.

The two Canadian companies are collaborating to integrate their technologies to solve a very costly healthcare problem. Despite operating in different spaces of the healthcare industry, both companies have evidence-based methodologies and validated solutions that complement each other. MEMOTEXT’s JAMA published clinically validated digital adherence solutions have been shown to increase patient adherence by 31.4%.


CDMN Soft Landing program announces latest cohort

By on Mar 9, 2015

Twenty-nine companies have been selected for the latest cohort of the Canadian Digital Media Network’s Soft Landing program.

Given the abundance of high-quality applications it received for the spring cohort, the Soft Landing program team decided to support as many applicants as possible. “When we see that many interested companies that have strong applications, we do what we can to allocate the funds to support the program,” said Lisa Cashmore, Soft Landing Program Manager.


Toronto alberga laboratorio de innovadores en tecnología avanzada

3 marzo, 2015 5:59 pm

Toronto, 3 Mar (Notimex).- Toronto, cuarta ciudad más grande de Norteamérica, rivaliza con Londres, Nueva York y Singapur en materia de oportunidades para hacer negocios a partir de un centro de innovación con tecnología de punta y una economía diversificada.

Poseedora de una economía diversificada, que se sustenta en la manufactura y la construcción, inyecta al país 286 mil millones de dólares anuales a partir de sus bajos costos de operación, señaló Michael Stewart, ejecutivo de negocios de Invest Toronto.


Medicaid Health Plan Offers Personalized Medication Adherence Platform for Asthma Patients

by HITC Staff 

AmeriHealth D.C., the largest Medicaid managed care organization in the District announced it will offer its members a personalized digital mobile platform aimed at improving medication adherence for asthma patients. The platform called HealthNHandSM launched by pharmacy benefits manager PerformRx was developed conjunction with MEMOTEXT, a health care technology company, is designed to improve adherence to treatment regimens.

How It Works

HealthNHand works on nearly any mobile phone with web browsing and SMS capabilities.Participants receive reminders to take their asthma medications and complete questionnaires about their health status via interactive voice response, short message service (SMS) or email. HealthNHand’s personalized information, targeted support and daily air quality forecasts, generated for each user based on results from the questionnaires, help asthma patients become more aware and engaged in their own self-care. Users may log on to the HealthNHand site to view their own data and progress.


DC Medicaid payor will offer med adherence texting platform for asthma patients

By: Jonah Comstock | Feb 24, 2015

A new text messaging software aimed at improving medication adherence will be offered to asthma patients who are members of AmeriHealth District of Columbia, Washington, D.C.’s largest Medicaid managed care organization. The platform, called HealthNHand, was developed by Memotext and will be launched by pharmacy benefit management company PerformRx.

HealthNHand will use interactive voice responses, email, and text messages to remind asthma patients in the program to take their medication and to fill out questionnaires about their health. The service will use data from the questionnaires to craft personalized responses to patients about their condition, including information, support, and air quality forecasts.


PerformRx Launches Personalized Digital Mobile Platform to Improve Medication Adherence for Asthma Patients



FOR IMMEDIATE RELEASE                                                                                                                  Contact: Michelle Davidson

February 24, 2015                                                                                                                                     215-208-9816



PerformRx Launches Personalized Digital Mobile Platform to Improve

Medication Adherence for Asthma Patients


HealthNHand helps health plans extend care management with

air quality and behavior change interventions


Philadelphia, PA – PerformRx, (www.performrx.com), a URAC-accredited, full service pharmacy benefits manager with industry-leading clinical programs, announced today the launch of HealthNHand, a personalized digital mobile platform aimed at improving medication adherence. HealthNHand will be initially offered to members of AmeriHealth District of Columbia, the largest Medicaid managed care organization in the District.


HealthNHand, developed by MEMOTEXT, a health care technology company, is designed to improve adherence to treatment regimens. Participants receive reminders to take their asthma medications and complete questionnaires about their health status via interactive voice response, short message service (SMS) or email. HealthNHand’s personalized information, targeted support and daily air quality forecasts, generated for each user based on results from the questionnaires, help asthma patients become more aware and engaged in their own self-care.



Made-in-Ontario healthcare innovations expanding south

by Lara Torvi – 20 Feb 2015

Three MaRS health ventures announced expansion in the US this week. The technologies they offer range from personalized disease prevention and medication monitoring to real-time surveillance technology that controls the spread of hospital-acquired infections.

Their push into the US market is a sign of the continued growth of Ontario-based health and life sciences companies that are developing new tools that not only prevent illness, but also help speed up healing. Health and life sciences companies in Ontario generate revenues of $39 billion a year, with almost $6 billion generated by exports to countries all over the world. With annual healthcare spending in the US reaching $3.8 trillion in 2014, these solutions are critical to the future of our health systems.


MaRS’ new District 20 means business


“This is a great space. We lobbied hard to get here.”

I’m sitting across from Eric Riz, founder of Empty Cubicle, in the boardroom of MaRS’ new co-working space, District 20. A 6,000 square foot section of the MaRS Heritage Building (in what I’m told is rumoured to be the old Toronto General morgue), District 20 blends 20th century facilities with 21st century function in a way most have come to expect from the innovation hub. The sandy-bricked space is filled with colour-coded, pod-like offices; minimalist yet comfortable furniture lines the hallways and common areas, which feature private booths for phone calls or a quick break-out meeting. The space feels warm and professional.

But Riz isn’t talking about the space as an office, or at least not entirely. He’s talking about it as an extension of MaRS. MaRS has a mixed history convincing startups to take residency in its space. Riz is frank in his contrarian opinion.


Automated Telecommunication-Based Reminders and Adherence With Once-Daily Glaucoma Medication Dosing

The Automated Dosing Reminder Study

Michael V. Boland, MD, PhD1,2; Dolly S. Chang, MD, PhD1,3; Travis Frazier, MD4; Ryan Plyler, BS5; Joan L. Jefferys, ScM3; David S. Friedman, MD, MPH, PhD1,3

JAMA Ophthalmol. July 2014, Vol 132, No. 7


Importance Topical glaucoma medications lower intraocular pressure and alter the course of the disease. Because adherence with glaucoma medications is a known problem, interventions are needed to help those patients who do not take their medications as prescribed.

Objective To assess the ability of an automated telecommunication-based intervention to improve adherence with glaucoma medications.

Design, Setting, and Participants We performed a prospective cohort study of medication adherence, followed by a randomized intervention for those found to be nonadherent, of individuals recruited from a university-based glaucoma subspecialty clinic. A total of 491 participants were enrolled in the initial assessment of adherence. Of those, 70 were nonadherent with their medications after 3 months of electronic monitoring and randomized to intervention and control groups.


Electronic Reminders Can Improve Glaucoma Patients’ Drug Adherence

May 22, 2014 By Gabriel Miller

NEW YORK – A considerable proportion of glaucoma patients don’t take their medicine as prescribed, but electronic monitoring and reminders can boost adherence, according to a pair of reports on a new study.

“We now have two randomized trials — including this one — that have demonstrated an approximately 20% increase in adherence with glaucoma medications in a group shown to be non-adherent,” Dr. Michael Boland, lead author of both papers, told Reuters Health by email.

“There are no other interventions that have shown this level of improvement in this group,” said Dr. Boland from Johns Hopkins University in Baltimore, Maryland.

Both papers were published online May 15 in JAMA Ophthalmology.



How One Healthcare Entrepreneur Created His Own Access

Christina Hernandez Sherwood on May 20, 2014.

Like many healthcare entrepreneurs, Amos Adler of MEMOTEXT found it difficult to access the stakeholders who could help to make his patient adherence company a success. The challenge, he said, is that access is dependent on how a startup can align with the business model of the stakeholders involved. “Can you get into their business model,” he said, “and can you get into the clinical workflow?”

To get around that, Adler and MEMOTEXT have found their own solution. “We’re in the midst of building out what we call ‘the alliance for adherence,'” he said. The alliance, Adler said, consists of a group of stakeholders who have access to patients and a common interest in patient adherence.

Here are other entrepreneurial insights from Adler:


Canadian University Develops New Program To Help Educate Expectant Moms

by Jennifer Corter, Apr. 27, 2014

In this ever-changing world of technology, it is amazing how quickly things change. For example, for a while now, when women were pregnant, they had the option of attending classes focused on prenatal education over the course of their pregnancies. But unfortunately, not everyone can attend these classes due to prior commitments, medical reasons or a variety of other reasons. They would end up missing out on these important educational experiences. But researchers at the University of British Columbia are aiming to change that through the use of educational text messages for these women.

The SmartMom Canada program was created to meet the needs in British Columbia’s northern health region. Researchers’ aim is to have women in that area try out the program, along with women in the Fraser Valley Health region. Patti Janssen, professor at UBC’s School of Population and Public Health is spearheading the initiative, along with the university’s Child and Family Research Institute.


UBC project hopes to deliver prenatal education via text

But SmartMom Canada initiative still needs to raise nearly $100,000


Researchers at the University of B.C. are extending the growing trend of digital health to the womb with a project aimed at delivering prenatal education by text to moms-to-be who can’t attend classes.

The program, SmartMom Canada, was created to meet a need in B.C.’s northern health region and will be piloted there and in the Fraser Valley Health region. Professor Patti Janssen of UBC’s School of Population and Public Health is leading the initiative in conjunction with the university’s Child and Family Research Institute.


PerformRx Goes Behind the Scenes to Get a Better Picture of Patient Adherence

By Lauren Flynn Kelly, Editor Drug Benefit News, January 24, 2014 Volume 15 Issue 2

Insurers, PBMs and pharmacies have myriad ways to make sure patients physically obtain their medications, from monitoring patients at the point of sale to automatic mail-order refills. But how can anyone be sure what happens once the patient is at home with that medication?

“That’s the piece that has always been missing in medication adherence,” observes Mesfin Tegenu, R.Ph., president of PerformRx, LLC, a wholly owned subsidiary of the AmeriHealth Caritas Family of Companies. And adherence is especially important for those “who are on multiple medications, who are confused about how many pills to take or when to take them,” he asserts. “So our goal is to see how we can help patients comply and how we can make sure that they take their medications.”


PM360 Presents Novel Patient-Centric Strategies

360 Staff, May 21st, 2013

Patient Centricity. You have probably heard that phrase a million times this year alone. After all, it is one of the biggest buzzwords of 2013. But there is a reason for that. Pharma needs to find a way to better reach and engage with patients—and this goes beyond ads that get them to ask their doctors about a specific brand. This is about better understanding patients and learning how pharma can better serve them. This is about improving patient adherence and outcomes.

The good news is that the industry gets that. We asked our readers for innovative patient-centric initiatives and strategies and our inboxes were flooded with responses. Of course, pharma is probably well aware that medical non-adherence costs the industry billions of dollars a year. (An estimated loss of $564 billion globally according to Capgemini Consulting.) But the industry also cares about giving patients a voice, providing them with tools that can help them stay on medication and creating an environment where they can connect with others like themselves.


A Spoonful of Sugar: Developing a Medication – Reminder App

Sticking to a health regimen means remembering to take prescribed medications. But studies of medication adherence show that patients often fail to stay with the program. A prescription drug survey published by the National Community Pharmacists Association (NCPA) revealed that nearly 50 percent of consumers said they forgot to take a prescribed medication, while 24 percent said they took less than the recommended dosage.

Against this backdrop, MEMOTEXT, a company focused on medication- and treatment-compliance programs, offers a medication-adherence service that issues reminders to a patient’s mobile phone, tablet, PC or landline. The service is offered in more than 26 countries.

We spoke to Amos Adler, founder and president of MEMOTEXT, about how the system works and what it was like developing for the growing healthcare app market.

Read more: A Spoonful of Sugar: Developing a Medication-Reminder App http://www.digitalinnovationgazette.com/blog/medication_reminder_healthcare_app_market/index.html#ixzz3GtLLyMGh
Follow us: @DIGMobileDev on Twitter | digitalinnovationgazette on Facebook


“Everyone is Different and People Change. Our Technology Should Know as Much and Adapt with us. MEMOTEXT Personalizes your Health Interaction Experience.”

Dec 19th, 2012. By Amos Adler

Prior to founding MEMOTEXT, Amos Adler was a business solutions architect for the Bell Canada Enterprises (BCE) group of Companies. While at Bell Canada, Bell Mobility and other operating entities, he managed the design, implementation and integration of various CRM, ERP, Voice/Speech Recognition, IVR and web 2.0 and CTI – legacy system integration initiatives.

MEMOTEXT is a professional services firm and SaaS engine that focusses solely on medication and treatment compliance programs for healthcare stakeholders. MEMOTEXT® specializes in evidence based personalization of patient compliance interventions.

With a proprietary methodology and The MEMOTEXT Personologic™ inference engine, we integrate behavior modification, education and real-time support into the everyday lives of patients using everyday technologies patients already have. Our ability to learn and remember previously reported knowledge, intentions and behaviors allows us to adapt communications to changing attitudes, knowledge levels and circumstances of each patient using best of breed, secure mobile, speech and social medication adherence tools.


MedCity News: America, the Land of mhealth Opportunity

 4:14 pm by Stephanie Baum.

The American mobile health app landscape is perceived as an open market for innovation. Yet the lack of any particular oversight or regulation specific to mobile health means there is a wide variety of apps on the market that swing from FDA approved medical devices to apps that make unproven medical claims.

But as so often happens in the early days of many industries, the ones that distinguish themselves by filling an unmet or inadequately addressed need or can be adapted to disparate systems, find a home and are widely used.



Automated Med Reminders Boost Adherence

June 8th, 2011.

Glaucoma, the world’s second leading cause of blindness, has a number of effective therapies to help those afflicted. Despite these solutions, non-adherence rates for those treatments are reported to be between thirty-seven and fifty-nine percent. Luckily, mobile health professionals are working on ways to solve this issue. One such company, Memotext, has been developing adherence technologies and may have proof that its solution will improve those statistics.

Memotext and Microsoft’s recent study (funded by Microsoft and conducted by Johns Hopkins University) measured the efficacy of using the Memotext adherence solution combined with Microsoft’s personal health tracking platform HealthVault. Patients received some combination of text message reminders and IVR messages to remind them about their medication regimen.




Back to Top